Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc

Lung cancer is a leading cause of cancer-associated mortality worldwide. The cisplatin (DDP)-based chemotherapy remains the foundation of treatment for the majority of patients affected by advanced non-small cell lung cancer (NSCLC). However, DDP-resistance limits the clinical utility of this drug i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Yufang, Yang, Dongyan, Yu, Yin, Xiang, Mei, Li, Haiwen, Yang, Jun, Li, Jingjing, Jiang, Danxian, Zhou, Hechao, Xu, Zumin, Yu, Zhonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802146/
https://www.ncbi.nlm.nih.gov/pubmed/29257330
http://dx.doi.org/10.3892/mmr.2017.8301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802146/
https://www.ncbi.nlm.nih.gov/pubmed/29257330
http://dx.doi.org/10.3892/mmr.2017.8301

Ejemplares similares